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A key message of Osawa and Singh’s review of cytomegalo-
virus infection in critically ill patients is that the infection
occurred in 25% of patients and was associated with worse
outcome [1]. Emphasis was placed on the lack of proof of
causality between infection and outcome, and reactivation
may reflect illness severity.
The herpesvirus family all cause latent infections in humans,
and similar rates of infection, morbidity and mortality have
also been reported in comparable patients with herpes
simplex virus [2,3]. Nevertheless, although infection rates with
latent herpesviruses appear high, the majority of seropositive
patients do not suffer reactivation. Acquisition of herpes-
viruses in infancy results in trivial clinical illness, suggesting
we have co-evolved effectively with these pathogens. Indeed
a recent report highlighted how herpesviruses offer
protection from bacterial infections [4]. Latent, but not acute,
infection conferred a 100-fold to 1,000-fold reduction in
bacterial burden due to IFNγ-dependent macrophage
activation. Latency with all herpesviruses in humans is
probably associated with frequent subclinical reactivation,
which may lead to reticuloendothelial cell priming [5].
We suggest that the sequelae of latent infection may not be
universally adverse in all patients, some of whom may be
protected from developing septic shock and never enter the
intensive care unit. Osawa and Singh suggested a study to
determine the role of antiviral agents; until the mechanisms
and significance of reactivation in different patient groups are
elucidated, however, such studies will prove difficult to
interpret. A pilot study of acyclovir in the prophylaxis of
herpesvirus infections in critical care is already underway in
the United Kingdom (ISRCTN29934637).
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